NCT02158897

Brief Summary

Evidence from bio-gerontology research from our laboratory and others have showed that short-term fasting/starvation (STS) can improve the efficacy of chemotherapy by protecting normal cells and tissues and potentially sensitizing malignant cells to chemo drugs. Furthermore, STS improves risk factors associated with aging and age-related disease in rodent models. Prolonged fasting, however, is difficult to implement and may not be feasible or safe in humans. We have developed a fasting-mimicking diet (FMD) that was well accepted in a pilot human trial. The objective of the study is to ascertain the impact of the fasting-mimicking diet given to adult subjects for 5 days a month for 3 consecutive months. The investigators hypothesize that the specially designed dietary regimen can reduce the risk factors for metabolic syndrome and biomarkers associated with aging and age-related diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P75+ for phase_1 healthy-volunteers

Timeline
Completed

Started Mar 2013

Longer than P75 for phase_1 healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 2, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 9, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

April 6, 2017

Status Verified

April 1, 2017

Enrollment Period

3.3 years

First QC Date

June 2, 2014

Last Update Submit

April 4, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Safety and feasibility of the Prolon diet

    Phase I: To obtain preliminary estimates of the feasibility and safety of a low calorie Prolon diet in adult subjects.

    1 and half years

  • Effect of Prolon diet on risk factors for metabolic syndrome and biomarkers of aging

    Phase II: To ascertain the impact of the calorie restricted special diet on the risk factors for metabolic syndrome and biomarkers associated with aging and age-related diseases: e.g. fasting glucose, glucose tolerance, blood pressure, abdominal obesity, lipid profile, circulating IGF-1 and IGFBP1.

    2 and half years

Secondary Outcomes (1)

  • Changes in cognitive functions before and after the dietary intervention.

    2 and half years

Study Arms (2)

Control

NO INTERVENTION

Participants will consume their normal diet. Body weight and physiological change at two time points (approximately 2-3 months apart) will be examined. The participants will be crossed over to the diet group.

Prolon Diet

EXPERIMENTAL

Participants will be provided with a 5-day supply of fasting-mimicking diet, including energy bars, soups, drink packets and dietary supplements. Participants will diet for 3 cycles. Each one-month cycle consists of 5 days of dieting with a calorie intake estimated at 600-1200 calories per day. The rest of the month participants will eat normally. After 3 cycles, participants will be examined again after consuming their normal diet after 2-3 months.

Other: Prolon diet

Interventions

3 cycles of a 5-day Prolon diet very month

Also known as: Fasting-mimicking diet
Prolon Diet

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Generally healthy adults
  • BMI \>19 kg/m\^2

You may not qualify if:

  • Severe hypertension (systolic BP \> 200 mm Hg and/or diastolic BP \> 105 mm Hg).
  • Underweight (BMI \< 19 kg/m\^2)
  • Females who are pregnant or nursing
  • Special dietary requirements incompatible with the study interventions
  • Significant food allergies which would make the subject unable to consume the study food
  • Alcohol dependency (alcohol intake greater than two drinks per day for women and three drinks per day for men).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Davis School of Gerontology

Los Angeles, California, 90089, United States

Location

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research assistant professor

Study Record Dates

First Submitted

June 2, 2014

First Posted

June 9, 2014

Study Start

March 1, 2013

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

April 6, 2017

Record last verified: 2017-04

Locations